🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

63+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 63 recruiting trials for “Clear cell renal carcinoma

Phase 1, PHASE2RecruitingNCT07097935

Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma

🏥 Jiangsu Hansoh Pharmaceutical Co., Ltd.📍 1 site📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT06942104

Imaging of Solid Tumors Using 18F-TRX

👨‍⚕️ Rahul Aggarwal, MD, University of California, San Francisco📍 1 site📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT06940518

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

👨‍⚕️ Pavlos Msaouel, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT06661720

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

🏥 Alliance for Clinical Trials in Oncology📍 399 sites📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06835972

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

👨‍⚕️ Martin Voss, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06699602

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

👨‍⚕️ Martin Voss, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06852638

CD70-targeted immunoPET Imaging of Malignant Cancers

👨‍⚕️ Jianjun Liu, Ph.D. & M.D., Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06819293

IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma

🏥 Grit Biotechnology📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06680089

CD70-targeted immunoPET Imaging of Kidney Cancer

👨‍⚕️ Wei Zhai, Ph.D. & M.D., Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06750419

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

🏥 Telix Pharmaceuticals (Innovations) Pty Limited📍 8 sites📅 Started Nov 2024View details ↗
RecruitingNCT06863857

Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer

👨‍⚕️ Francesco Massari, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 2 sites📅 Started Sep 2024View details ↗
Phase 1, PHASE2RecruitingNCT06413680

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 11 sites📅 Started Sep 2024View details ↗
RecruitingNCT06676527

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

👨‍⚕️ Yuxiu Liu, M. D., Jinling Hospital, China📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06447103

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

👨‍⚕️ Brian Shuch, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06536439

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

👨‍⚕️ Charles Van Praet, MD, PhD, University Hospital, Ghent📍 5 sites📅 Started Jun 2024View details ↗
Phase 2RecruitingNCT06690697

Combination of Toripalimab and JS004 Therapy for ccRCC

🏥 Fudan University📍 1 site📅 Started Jun 2024View details ↗
Phase 1RecruitingNCT06234605

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

🏥 HiberCell, Inc.📍 20 sites📅 Started Apr 2024View details ↗
RecruitingNCT06349642

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

👨‍⚕️ Dev Mukhopadhyay, PhD, Mayo Clinic📍 3 sites📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06613269

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06211790

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

🏥 Fudan University📍 1 site📅 Started Jan 2024View details ↗
← PreviousPage 2 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →